Edinburgh born and bred, educated at Fettes, Roger studied Marine Biology at St Andrews and Public Health Research at Edinburgh before reading Medicine and completing Foundation training in Dundee in 2014.

Caring for a patient in pain at the end of their life during his first two weeks as a Foundation doctor led Roger to create the Safer Prescription of Opioids Tool (SPOT). Now a medical device, it has helped over 2,000 patients in pain at the end of their lives, was commercially adopted by NHS Borders, included in Scottish Government policy, and recommended for national adoption by the Scottish Partnership for Palliative Care. SPOT was awarded a national prize, the Royal College of Surgeons Edinburgh's Dundas Medal for efforts to improve the provision of palliative care in hospital.

Roger was subsequently selected for the Harvard HealthTech Fellowship, applying the Biodesign Process to identify unmet clinical needs, based between HBS, HMS, SEAS and Mass. Eye and Ear infirmary, where he was awarded a Gliklich Healthcare Innovation Scholarship. He undertook further training in Value-Based Health Care, Venture capital and Private Equity at HBS and Substance Use Disorder Ventures at MIT, returning to the UK to complete his GP training.

Roger is also Yeoman of the 'The Worshipful Society of Apothecaries of London'.

In his spare time, Roger served for 17 years in the British Army Reserve, retiring as a Major in 215 Multi-role Medical Regiment with overseas deployments and VRSM, QPJM and KCM awards for efficient service.

In addition to his clinical work, Roger consults for VCs, NHS bodies, universities and start-ups in Health and MedTech, mentors at Mass Challenge, Harvard iLabs and the NHS Clinical Entrepreneurship programme. He is building a UK-US transatlantic healthcare venture capital fund.